Drug Profile
Research programme: targeted apoptosis inducer - multimmune
Alternative Names: mi-APOLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator multimmune
- Class Enzymes
- Mechanism of Action HSP70 heat-shock protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Solid-tumours in Germany
- 19 Jul 2012 Early research in Solid tumours in Germany (unspecified route)